Suppr超能文献

二十年立法——澳大利亚如何应对临床中转基因生物监管的挑战

20 Years of Legislation - How Australia Has Responded to the Challenge of Regulating Genetically Modified Organisms in the Clinic.

作者信息

O'Sullivan Gabrielle M, Philips Joshua G, Mitchell Heidi J, Dornbusch Michael, Rasko John E J

机构信息

Research Ethics and Governance Office, Royal Prince Alfred Hospital, Sydney Local Health District, Sydney, NSW, Australia.

Office of the Gene Technology Regulator, Australian Government Department of Health, Canberra, ACT, Australia.

出版信息

Front Med (Lausanne). 2022 May 10;9:883434. doi: 10.3389/fmed.2022.883434. eCollection 2022.

Abstract

•In contrast to the prior voluntary system, since 2001, gene technology in Australia has been regulated under a legislated national Gene Technology Regulatory Scheme which is administered by the Gene Technology Regulator.•The Scheme provides science-based assessment of the potential risks of gene technology to the health and safety of people and the environment.•It complements the role of the Australian Therapeutic Goods Administration which regulates all therapeutic products in Australia to ensure they are safe and effective.•Recent reforms to the Scheme contribute to, and anticipate, the continued safe development and delivery of gene-based human therapeutics in Australia as a successful model for other jurisdictions.

摘要

与先前的自愿制度不同,自2001年以来,澳大利亚的基因技术一直依据一项由基因技术监管机构管理的法定国家基因技术监管计划进行监管。

该计划对基因技术给人类健康和安全以及环境带来的潜在风险进行基于科学的评估。

它补充了澳大利亚治疗用品管理局的作用,该局对澳大利亚所有治疗产品进行监管,以确保其安全有效。

该计划最近的改革有助于并预期澳大利亚将继续安全地开发和提供基于基因的人类治疗方法,成为其他司法管辖区的成功典范。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c383/9127347/56e645969467/fmed-09-883434-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验